Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-600
Closed -$10.8K 12352
2025
Q1
$10.8K Sell
600
-300
-33% -$5K ﹤0.01% 13526
2024
Q4
$14.3K Buy
900
+700
+350% +$11.5K ﹤0.01% 13409
2024
Q3
$3.41K Buy
200
+100
+100% +$1.73K ﹤0.01% 13658
2024
Q2
$1.76K Buy
+100
New +$1.74K ﹤0.01% 13781
2023
Q4
Sell
-2,500
Closed -$39.5K 14188
2023
Q3
$39.5K Sell
2,500
-2,500
-50% -$38.5K ﹤0.01% 12006
2023
Q2
$70.2K Buy
5,000
+1,000
+25% +$12.2K ﹤0.01% 11386
2023
Q1
$44.6K Buy
+4,000
New +$52.5K ﹤0.01% 12308
2020
Q1
Sell
-9,000
Closed -$244K 9528
2019
Q4
$244K Buy
+9,000
New +$243K ﹤0.01% 7886

Other funds holding AFYA

Citadel Advisors's AFYA Position: Q2 2026 in Review

Citadel Advisors increased its Afya (AFYA) stake by 122% in Q2 2026, buying an estimated $866K and bringing the position to 108,590 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #7035.

Citadel Advisors first reported a position in AFYA in Q4 2019 and has held it in 23 quarters since. The position peaked at $3.8M in Q4 2022. 55 funds tracked by Wall St. Rank hold AFYA as of Q2 2026.

  • Citadel Advisors held 108,590 shares of Afya worth $1.61M as of Q2 2026.
  • Citadel Advisors bought 59,703 Afya shares in Q2 2026, an estimated $866K.
  • Afya made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7035 holding.
  • Citadel Advisors first reported a position in Afya in Q4 2019 and has held it in 23 quarters since.
  • Citadel Advisors's Afya position peaked at $3.8M in Q4 2022.
  • 55 funds tracked by Wall St. Rank held Afya as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.